Custom CRISPR/Cas9-mediated gene knock-in services for stable integration of your gene of interest into the Pseudomonas putida genome.
Pseudomonas putida is a versatile, safe (GRAS) industrial chassis. Our CRISPR/Cas9 knock-in service precisely inserts your gene of interest at defined genomic loci, enabling stable overexpression or functional studies without plasmid loss.
Our service combines target-specific guide RNA design, donor template construction with homology arms, and efficient delivery into P. putida to achieve precise, stable genomic integration.
We select optimal target sites and design custom guide RNAs together with donor templates carrying your gene of interest flanked by homology arms (typically 500–1000 bp each). All designs are reviewed in silico for specificity and efficiency.
Cas9, guide RNA, and donor template are delivered into P. putida cells via electroporation or conjugation. Following selection, we screen colonies by PCR and Sanger sequencing to confirm correct knock-in at the intended genomic site.
Service is adaptable to common P. putida strains (e.g., KT2440, DOT-T1E, and other laboratory or environmental isolates) with project-specific optimization of transformation efficiency.
Choose antibiotic resistance markers (gentamicin, kanamycin, streptomycin) or auxotrophic complementation for marker recycling, depending on your downstream application requirements.
Each knock-in strain is verified by PCR, Sanger sequencing, and optionally by qPCR or whole-genome sequencing (as scoped) to confirm single-copy integration and absence of unintended genomic rearrangements.
Every project delivers a verified engineered P. putida strain plus all supporting data and materials to continue your research.
The table below outlines typical project specifications. All parameters are customized based on your gene, target locus, and downstream application; final scope is defined in the project SOW.
| Parameter | Typical project scope |
|---|---|
| Host Strain | Pseudomonas putida KT2440 (default); other strains (e.g., DOT-T1E, S12) evaluated on a case-by-case basis |
| Gene of Interest Size | Scoped per project after consultation |
| Homology Arm Length | Scoped per project after consultation |
| Selection Marker | Gentamicin, kanamycin, or streptomycin resistance; auxotrophic complementation (e.g., pyrF) available for marker recycling |
| Integration Site | Intergenic neutral sites (e.g., attTn7, GG1) or a genomic locus of your choice (if transcriptionally silent region) |
| Number of Clones Screened | Colonies per project; additional screening scoped as needed |
| Verification Method | PCR (junction-spanning) + Sanger sequencing of integration sites; optional qPCR for copy number or WGS for whole-genome validation |
| Deliverables Timeframe | Scoped per project after consultation |
From sequence submission to delivered strain, our five-step process ensures transparent progress and rigorous quality control at each stage.
You provide the gene of interest and target locus (or we select an intergenic neutral site). Our team designs one to two guide RNAs in the proximity of the integration site and performs in silico off-target analysis. Approved designs move to plasmid construction.
We clone the gene of interest flanked by homology arms into a donor vector carrying a selection marker. The guide RNA is cloned into a Cas9 expression plasmid. All constructs are sequence-verified before delivery to the next step.
Competent P. putida cells are co-transformed with the Cas9/gRNA plasmid and the donor template (or delivered as a ribonucleoprotein complex). We evaluate cell preparation and electroporation parameters to evaluate integration efficiency.
Transformants are plated on selective media. Individual colonies are picked and screened by colony PCR using primers spanning the integration junctions. Positive hits are confirmed by Sanger sequencing of the entire inserted region.
At least one confirmed knock-in clone is re-streaked to support clonal purity. We perform final PCR and sequencing across the integration site, prepare glycerol stocks, and generate a project report including methods, QC, and datasets. The engineered strain and all materials are shipped.
Our service supports a wide range of research and industrial goals where stable genomic expression is required.
Insert heterologous biosynthetic genes for production of specialty chemicals, biopolymers, or natural products directly into the genome for stable, marker-free expression.
Integrate a gene of interest under a constitutive or inducible promoter to study gain-of-function phenotypes without plasmid maintenance or copy-number variability.
Integrate enzymes that degrade recalcitrant pollutants (PCBs, explosives) or catalyze stereo-selective transformations for green chemistry applications.
Answers to common questions about our P. putida gene knock-in service, including scope, QC, and project handoff.
Knock-in efficiency depends on the target locus, homology arm design, and strain background. Under standard conditions, we typically observe project-dependent performance that is verified during development integration among selected colonies. Final success is evaluated during the screening step; if no correct integrants are obtained, we redesign the guide RNA or homology arms at no additional charge (within the original project scope).
Our protocol drives integration via double-crossover homologous recombination, which is inherently stable. In strains where a selection marker is retained, we confirm marker presence. For markerless knock-ins (using counter-selection), we investigate the integration by PCR/sequencing and provide a working glycerol stock. Long-term stability can be assessed as a follow-up service if requested.
Our standard service supports inserts up to approximately 5 kb. For larger clusters, we can design a multi-step integration strategy using serial knock-ins or a two-vector system. Please contact us to discuss feasibility and appropriate timelines for large constructs.
You receive PCR gel images showing specific amplification across both homology arms, Sanger sequencing electropherograms of the entire integrated region, and a summary table of tested colonies. Optional whole-genome sequencing (WGS) or qPCR for copy number assessment can be added to the project scope.
Get a customized quote for your Pseudomonas putida Gene Knock-in project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.